X
Search
X

Patient Support Hotline

Call (844) 244-1309

ZERO360 is a free, comprehensive patient support service to help patients and their families navigate insurance and financial obstacles to cover treatment and other critical needs associated with cancer.

X

Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

  • Patient Support (844) 244-1309
  • Search
  • e-News Signup Enews Signup
  • Run/Walk
  • Donate

The MIRAGE Randomized Clinical Trial

Emerging clinical trial data have demonstrated stereotactic body radiotherapy (SBRT), a form of radiation in which large daily doses are delivered with high precision in generally 5 or fewer treatments, to be a curative option for very low-risk through very high-risk prostate cancer.15 Traditionally, SBRT has been delivered using linear accelerators (LINACs) relying on computed tomography (CT)–based planning techniques and the use of either planar x-ray or cone-beam CT images to guide radiation delivery. While generally well tolerated, both acute and late toxic effects can manifest as urinary, bowel, and sexual dysfunction and contribute to treatment-related burden…

Read more about the MIRAGE Randomized Clinical Trial.

 

source: Amar Kishan - JAMA Network